MCID: NSL004
MIFTS: 24

Nasal Cavity Lymphoma

Categories: Blood diseases, Cancer diseases, Immune diseases, Respiratory diseases

Aliases & Classifications for Nasal Cavity Lymphoma

MalaCards integrated aliases for Nasal Cavity Lymphoma:

Name: Nasal Cavity Lymphoma 12 15 74
Lymphoma of the Nasal Cavity 12
Lymphoma of Nasal Cavity 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10813
NCIt 51 C6074
UMLS 74 C1334921

Summaries for Nasal Cavity Lymphoma

MalaCards based summary : Nasal Cavity Lymphoma, also known as lymphoma of the nasal cavity, is related to b-cell lymphomas and diffuse large b-cell lymphoma. An important gene associated with Nasal Cavity Lymphoma is ANKRD11 (Ankyrin Repeat Domain 11). The drugs Ifosfamide and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include t cells, b cells and kidney.

Related Diseases for Nasal Cavity Lymphoma

Diseases related to Nasal Cavity Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 b-cell lymphomas 10.1
2 diffuse large b-cell lymphoma 9.9
3 lymphoproliferative syndrome 9.9
4 rhinitis 9.9
5 dacryoadenitis 9.9
6 lymphoma 9.9

Graphical network of the top 20 diseases related to Nasal Cavity Lymphoma:



Diseases related to Nasal Cavity Lymphoma

Symptoms & Phenotypes for Nasal Cavity Lymphoma

Drugs & Therapeutics for Nasal Cavity Lymphoma

Drugs for Nasal Cavity Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ifosfamide Approved Phase 2 3778-73-2 3690
2
Etoposide Approved Phase 2 33419-42-0 36462
3
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
4
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
5
Pembrolizumab Approved Phase 2 1374853-91-4
6
Isophosphamide mustard Phase 2 0
7
asparaginase Phase 2
8 Etoposide phosphate Phase 2
9 BB 1101 Phase 2
10 Antineoplastic Agents, Immunological Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma Completed NCT01007526 Phase 2
2 Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type Recruiting NCT03728972 Phase 2 Pembrolizumab

Search NIH Clinical Center for Nasal Cavity Lymphoma

Genetic Tests for Nasal Cavity Lymphoma

Anatomical Context for Nasal Cavity Lymphoma

MalaCards organs/tissues related to Nasal Cavity Lymphoma:

42
T Cells, B Cells, Kidney, Nk Cells

Publications for Nasal Cavity Lymphoma

Articles related to Nasal Cavity Lymphoma:

(show all 15)
# Title Authors Year
1
Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder. ( 29843925 )
2018
2
Lymphoma of the nasal cavity and paranasal sinuses: A case series. ( 27657899 )
2016
3
NK/T-cell lymphoma of the nasal cavity causing contralateral dacryoadenitis. ( 23663138 )
2013
4
Diffuse large B-cell lymphoma of the nasal cavity presenting as abducens nerve palsy. ( 24220442 )
2013
5
Pathology in practice. Nonepitheliotropic B-cell lymphoma of the nasal cavity with associated suppurative rhinitis and epidermal ulceration and lymphoma of the right kidney. ( 22380803 )
2012
6
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. ( 17166382 )
2006
7
EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient. ( 16364984 )
2006
8
Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. ( 12576916 )
2003
9
Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. ( 11728681 )
2001
10
Primary non-Hodgkin's lymphoma of the nasal cavity. Clinical case report and discussion. ( 10958410 )
2000
11
Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. ( 9690537 )
1998
12
Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. ( 9240537 )
1997
13
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. ( 9241082 )
1997
14
[Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases]. ( 1890745 )
1991
15
Primary lymphoma of the nasal cavity. A case report. ( 3616212 )
1987

Variations for Nasal Cavity Lymphoma

Expression for Nasal Cavity Lymphoma

Search GEO for disease gene expression data for Nasal Cavity Lymphoma.

Pathways for Nasal Cavity Lymphoma

GO Terms for Nasal Cavity Lymphoma

Cellular components related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.62 B2M IGHV4-38-2

Biological processes related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 8.62 IGHV4-38-2 B2M

Sources for Nasal Cavity Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....